Purple Biotech
PPBT
10 hedge funds and large institutions have $224K invested in Purple Biotech in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
4,020% more call options, than puts
Call options by funds: $412K | Put options by funds: $10K
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
17% less funds holding
Funds holding: 12 → 10 (-2)
28% less capital invested
Capital invested by funds: $311K → $224K (-$87.2K)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAOI
Wealth Advisors of Iowa
West Des Moines,
Iowa
|
+$26.6K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$14K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
+$8.41K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$33K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$28K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$26.6K |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$6.54K |
| 5 |
Morgan Stanley
New York
|
-$1.4K |
PPBT Hedge Fund Activity: Q3 2022 in Review
10 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Purple Biotech (PPBT) for Q3 2022, worth a combined $224K — down 28% from $311K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of PPBT and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 2 added.
The largest buyer was Wealth Advisors of Iowa, opening a new position worth an estimated $26.6K. The largest seller was Virtu Financial, exiting entirely with an estimated $33K sold.
- 10 institutional investors held Purple Biotech (PPBT) as of Q3 2022, down from 12 in Q2 2022.
- Funds reported $224K of Purple Biotech stock for Q3 2022, down 28% quarter-over-quarter.
- 1 fund opened new Purple Biotech positions in Q3 2022 and 3 closed out, a net change of -2 holders.
- The largest Purple Biotech buyer in Q3 2022 was Wealth Advisors of Iowa, an estimated $26.6K added.
- The largest Purple Biotech seller in Q3 2022 was Virtu Financial, an estimated $33K sold.
Based on aggregated 13F filings for Q3 2022.